Thus, when combined with recent evidence of Del-1 as a diagnostic and potential prognostic marker of breast cancer [8], our results identify novel mRNA/miRNA interactions that contribute to TNBC via a Del-1 mechanism and that represent potential targets for the development of new therapeutic strategies for TNBC. This evidence concerns the gene EDIL3 and breast carcinoma.